Dynavax (NASDAQ: DVAX) reported Q3 EPS of ($0.24), versus ($0.15) reported last year. Revenue for the quarter came in at $108.3 million, versus $13.41 million reported last year.

For earnings history and earnings-related data on Dynavax (DVAX) click here.